Staff Publications: February 2018

1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter Evaluation of the Clinical Utility of Laparoscopy-Assisted Ercp in Patients with Roux-En-Y Gastric Bypass. Gastrointestinal Endoscopy. 2018.

2. Abbosh PH, Plimack ER. Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer. Bladder Cancer. 2018;4(1):9-18. PMID: 29430503. PMC5798524.

3. Adamsky MA, Boysen WR, Cohen AJ, et al. Evaluating the Role of Postoperative Oral Antibiotic Administration in Artificial Urinary Sphincter and Inflatable Penile Prosthesis Explantation: A Nationwide Analysis. Urology. 2018;111:92-98.

4. Al-Kawas F, Aslanian H, Baillie J, et al. Percutaneous Transhepatic Vs. Endoscopic Retrograde Biliary Drainage for Suspected Malignant Hilar Obstruction: Study Protocol for a Randomized Controlled Trial. Trials. 2018;19(1):108. PMID: 29444707. PMC5813390.

5. Araiza-Olivera D, Feng Y, Semenova G, Prudnikova TY, Rhodes J, Chernoff J. Suppression of Rac1-Driven Malignant Melanoma by Group a Pak Inhibitors. Oncogene. 2018;37(7):944-952.

6. Atkins MB, Plimack ER, Puzanov I, et al. Axitinib in Combination with Pembrolizumab in Patients with Advanced Renal Cell Cancer: A Non-Randomised, Open-Label, Dose-Finding, and Dose-Expansion Phase 1b Trial. Lancet Oncol. 2018. PMID: 29439857.

7. Bagrodia A, Woldu S, Penson DF, Kutikov A, Kaffenberger SD. Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, Et Al. Contemporary Treatment Patterns and Outcomes for Clinical Stage Is Testicular Cancer. Eur Urol. In Press. Http://Dx.Doi.Org/10.1016/J.Eururo.2017.06.013. Eur Urol. 2017.

8. Barr PM, Li H, Burack WR, et al. R-Chop, Radioimmunotherapy, and Maintenance Rituximab in Untreated Follicular Lymphoma (Swog S0801): A Single-Arm, Phase 2, Multicentre Study. Lancet Haematol. 2018. PMID: 29396094.

9. Bartel MJ, Puri R, Brahmbhatt B, et al. Correction To: Endoscopic and Surgical Management of Nonampullary Duodenal Neoplasms. Surg Endosc. 2018. PMID: 29468272.

10. Bartel MJ, Puri R, Brahmbhatt B, et al. Endoscopic and Surgical Management of Nonampullary Duodenal Neoplasms. Surg Endosc. 2018. PMID: 29392469.

11. Bradbury AR, Patrick-Miller LJ, Egleston BL, et al. Randomized Noninferiority Trial of Telephone Vs in-Person Disclosure of Germline Cancer Genetic Test Results. J Natl Cancer Inst. 2018. PMID: 29490071.

12. Cagney DN, Martin AM, Catalano PJ, et al. Impact of Pemetrexed on Intracranial Disease Control and Radiation Necrosis in Patients with Brain Metastases from Non-Small Cell Lung Cancer Receiving Stereotactic Radiation. Radiother Oncol. 2018. PMID: 29398153.

13. Carqueijeiro I, Duge de Bernonville T, Lanoue A, et al. A Bahd Acyltransferase Catalyzing 19-O-Acetylation of Tabersonine Derivatives in Roots of Catharanthus Roseus Enables Combinatorial Synthesis of Monoterpene Indole Alkaloids. Plant J. 2018. PMID: 29438577.

14. Cheng D, Zhao S, Tang H, et al. Microrna-20a-5p Promotes Colorectal Cancer Invasion and Metastasis by Downregulating Smad4. Oncotarget. 2016;7(29):45199-45213. PMID: 27286257. PMC5216716.

15. Churilla TM, DeMora L, Handorf E, et al. Deviations from Standard Chemoradiation among Early-Stage Anal Cancer Patients. Int J Radiat Oncol Biol Phys. 2018;100(4):945-949. PMID: 29485073.

16. Czyz M, Toma M, Gajos-Michniewicz A, et al. Parp1 Inhibitor Olaparib (Lynparza) Exerts Synthetic Lethal Effect against Ligase 4-Deficient Melanomas. Oncotarget. 2016;7(46):75551-75560. PMID: 27705909. PMC5342760.

17. Doss M. Comment on ’30 Years Follow-up and Increased Risks of Breast Cancer and Leukaemia after Long-Term Low-Dose-Rate Radiation Exposure’. Br J Cancer. 2018. PMID: 29438374.
18. Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in Trk Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378(8):731-739. PMID: 29466156.

19. Egleston BL, Pedraza O, Wong YN, Griffin CL, Ross EA, Beck JR. Temporal Trends and Characteristics of Clinical Trials for Which Only One Racial or Ethnic Group Is Eligible. Contemporary Clinical Trials Communications. 2018;9:135-142.

20. Elliott B, Zackery DL, Eaton VA, et al. Ethnic Differences in Tgfbeta Signaling Pathway May Contribute to Prostate Cancer Health Disparity. Carcinogenesis. 2018. PMID: 29474521.

21. Erkmen CP, Moore RF, Belden C, et al. Overcoming Barriers to Lung Cancer Screening by Implementing a Single-Visit Patient Experience. Int J Cancer Oncol. 2017;4(2). PMID: 29399636. PMC5796669. NIHMS888832.

22. Escudier B, Sharma P, McDermott DF, et al. Erratum to “Checkmate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma” [Eur Urol 2017;72:962-71]. Eur Urol. 2018.

23. Fahl SP, Coffey F, Kain L, et al. Role of a Selecting Ligand in Shaping the Murine Gammadelta-Tcr Repertoire. Proc Natl Acad Sci U S A. 2018;115(8):1889-1894. PMID: 29432160.

24. Fang CY, Tseng M. Ethnic Density and Cancer: A Review of the Evidence. Cancer. 2018. PMID: 29411868.

25. Frankel AS, Bass SB, Patterson F, Dai T, Brown D. Sexting, Risk Behavior, and Mental Health in Adolescents: An Examination of 2015 Pennsylvania Youth Risk Behavior Survey Data. J Sch Health. 2018;88(3):190-199. PMID: 29399839.

26. Fundakowski CE, Hales NW, Agarwal N, et al. Surgical Management of the Recurrent Laryngeal Nerve in Thyroidectomy: American Head and Neck Society Consensus Statement. Head Neck. 2018. PMID: 29461666.

27. Gerhard GS, Fisher SG, Feldman AM. Genetic Testing for Inherited Cardiac Diseases in Underserved Populations of Non-European Ancestry: Double Disparity. JAMA Cardiol. 2018. PMID: 29490336.

28. Giri VN, Knudsen KE, Kelly WK, et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. Journal of Clinical Oncology. 2018;36(4):414-424.

29. Godwin JL, Hoffman-Censits J, Plimack E. Recent Developments in the Treatment of Advanced Bladder Cancer. Urol Oncol. 2018. PMID: 29395952.

30. Goetz A, Nweze N, Joshi A, Farma J. Synchronous Subcutaneous Granular Cell Tumours, a Rare Presentation. Ann R Coll Surg Engl. 2018:e1-e3. PMID: 29484942.

31. Gordon RE, Zhang L, Peri S, et al. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma. Clin Cancer Res. 2018. PMID: 29437795.

32. Haifler M, Pence I, Sun Y, et al. Discrimination of Malignant and Normal Kidney Tissue with Short Wave Infra-Red Dispersive Raman Spectroscopy. J Biophotonics. 2018. PMID: 29411949.

33. Handorf EA, Heitjan DF, Bekelman JE, Mitra N. Estimating Cost-Effectiveness from Claims and Registry Data with Measured and Unmeasured Confounders. Stat Methods Med Res. 2018:962280218759137. PMID: 29468944.

34. Handra-Luca A, Wei S. Intrathyroid Cystic Thyroglossal Duct Remnant and Ectopic Thymus: A Fortuitous or Development-Related Association? Surg Today. 2018. PMID: 29460127.

35. Harshman LC, Chen YH, Liu G, et al. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation with or without Docetaxel. Journal of Clinical Oncology. 2018;36(4):376-382.

36. Hernandez-Borrero LJ, Zhang S, Lulla A, Dicker DT, El-Deiry WS. Cb002, a Novel P53 Tumor Suppressor Pathway-Restoring Small Molecule Induces Tumor Cell Death through the Pro-Apoptotic Protein Noxa. Cell Cycle. 2018:1-11.

37. Horwitz SM, Ansell SM, Ai WZ, et al. T-Cell Lymphomas, Version 2.2018 Featured Updates to the Nccn Guidelines. JNCCN Journal of the National Comprehensive Cancer Network. 2018;16(2):123-135.

38. Jain R, Dotan E. Nutrition and Aging: A Practicing Oncologist’s Perspective. Current Oncology Reports. 2017;19(11).

39. Kamboj M, Brite J, Aslam A, et al. Artificial Differences in Clostridium Difficile Infection Rates Associated with Disparity in Testing. Emerging Infectious Diseases. 2018;24(3):584-587.

40. Karlova MG, Volokh OI, Chertkov OV, Kirpichnikov MP, Studitsky VM, Sokolova OS. Purification and Concentration of Rna Polymerase on Ni-Lipid Monolayers. Russian Journal of Bioorganic Chemistry. 2017;43(6):658-663.

41. Kasimova MA, Yazici A, Yudin Y, et al. Ion Channel Sensing: Are Fluctuations the Crux of the Matter? J Phys Chem Lett. 2018:1260-1264. PMID: 29439562.

42. Katsnelson M, Hwang WT, Tahirovic E, Rubin SC, Tanyi JL. Preoperative Predictors That Impact the Survival and Outcome of Patients Undergoing Secondary Cytoreduction for Ovarian Cancer. J Obstet Gynaecol. 2018:1-7. PMID: 29385863.

43. Kishan AU, Shaikh T, Wang PC, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated with Radiotherapy or Radical Prostatectomy: A Multi-Institutional Comparative Analysis. Eur Urol. 2017;71(5):766-773. PMID: 27452951.

44. Koch C, Schwing AM, Herrmann E, et al. Bevacizumab-Based First-Line Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer: An Individual Patient Data Based Meta-Analysis. Oncotarget. 2018;9(12):10272-10283.

45. Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(2):170-199.

46. Lee CT, Dong Y, Li T, et al. Local Control and Toxicity of External Beam Reirradiation with a Pulsed Low-Dose-Rate Technique. Int J Radiat Oncol Biol Phys. 2018;100(4):959-964. PMID: 29485075.

47. Localio AR, Goodman SN, Meibohm A, et al. Statistical Code to Support the Scientific Story. Ann Intern Med. 2018. PMID: 29404564.

48. Lounsbury N, Eidem T, Colquhoun J, et al. Novel Inhibitors of Staphylococcus Aureus Rnpa That Synergize with Mupirocin. Bioorg Med Chem Lett. 2018. PMID: 29463447.

49. Majtan T, Jones W, Jr., Krijt J, et al. Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria. Mol Ther. 2017. PMID: 29398487.

50. Marty R, de Prisco N, Carter H, Font-Burgada J. Mhc-I Genotype Drives Early Immune Selection of Oncogenic Mutations. Mol Cell Oncol. 2018;5(2):e1409863. PMID: 29487895. PMC5821412.

51. Matthew EM, Yang Z, Peri S, et al. Plk2 Loss Commonly Occurs in Colorectal Carcinomas but Not Adenomas: Relationship to Mtor Signaling. Neoplasia. 2018;20(3):244-255. PMID: 29448085.

52. Mehren MV, Joensuu H. Gastrointestinal Stromal Tumors. Journal of Clinical Oncology. 2018;36(2):136-143.

53. Messina NM, Rossi K, Wetherhold LM, et al. Optimizing Donor Site Closure Following Bilateral Breast Reconstruction with Abdominal-Based Free Flaps. Journal of Plastic Reconstructive and Aesthetic Surgery. 2018;71(2):269-271.

54. Mortazavi SAR, Mortazavi SMJ. Women with Hereditary Breast Cancer Predispositions Should Avoid Using Their Smartphones, Tablets, and Laptops at Night. Iran J Basic Med Sci. 2018;21(2):112-115. PMID: 29456806. PMC5811748.

55. Mortazavi SMJ. Cell Phones, Cancer, and Other Problems. Physics Teacher. 2018;56(3):131.

56. Mortazavi SMJ. Comments on “Physician Knowledge of Radiation Exposure and Risk in Medical Imaging”. J Am Coll Radiol. 2018. PMID: 29398502.

57. Mortazavi SMJ. Comments on “Sesamol Ameliorates Radiation Induced DNA Damage in Hematopoietic System of Whole Body -Irradiated Mice”. Environmental and Molecular Mutagenesis. 2018;59(2):170-171.

58. Mortazavi SMJ. Comments on “Sesamol Ameliorates Radiation Induced DNA Damage in Hematopoietic System of Whole Body Γ-Irradiated Mice”. Environmental and Molecular Mutagenesis. 2018;59(2):170-171.

59. Mortazavi SMJ, Bevelacqua JJ, Fornalski KW, et al. Letter to the Editor (August 24, 2017) Concerning the Paper “Occupational Exposure to Radon for Underground Tourist Routes in Poland: Doses to Lung and the Risk of Developing Lung Cancer”. Int J Occup Med Environ Health. 2018. PMID: 29416140.

60. Mortazavi SMJ, Mortazavi G. Re: Blood Mercury Concentration in Relation to Metabolic and Weight Phenotypes Using the Knhanes 2011-2013 Data. International Archives of Occupational and Environmental Health. 2018;91(2):247-247.

61. Moten AS, Movva S, von Mehren M, et al. Granular Cell Tumor Experience at a Comprehensive Cancer Center. Journal of Surgical Research. 2018;226:1-7.

62. Naaman H, Rabinski T, Yizhak A, et al. Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells. Cell Reprogram. 2018;20(1):17-26. PMID: 29412740. PMC5804099.

63. Nikonova AS, Deneka AY, Kiseleva AA, et al. Ganetespib Limits Ciliation and Cystogenesis in Autosomal-Dominant Polycystic Kidney Disease (Adpkd). Faseb j. 2018:fj201700909R. PMID: 29401581.

64. Norquist BM, Brady MF, Harrell MI, et al. Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in Gog 218: An Nrg Oncology/Gynecologic Oncology Group Study. Clinical Cancer Research. 2018;24(4):777-783.

65. Overman MJ, Morris V, Moinova H, et al. Phase I/Ii Study of Azacitidine and Capecitabine/Oxaliplatin (Capox) in Refractory Cimp-High Metastatic Colorectal Cancer: Evaluation of Circulating Methylated Vimentin. Oncotarget. 2016;7(41):67495-67506. PMID: 27542211. PMC5341892.

66. Ozdemir AY, Rusanov T, Kent T, Siddique LA, Pomerantz RT. Polymerase Theta-Helicase Efficiently Unwinds DNA and Rna-DNA Hybrids. J Biol Chem. 2018. PMID: 29444826.

67. Podszywalow-Bartnicka P, Cmoch A, Wolczyk M, et al. Increased Phosphorylation of Eif2alpha in Chronic Myeloid Leukemia Cells Stimulates Secretion of Matrix Modifying Enzymes. Oncotarget. 2016;7(48):79706-79721. PMID: 27802179. PMC5346746.

68. Prabhu VV, Talekar MK, Lulla AR, et al. Single Agent and Synergistic Combinatorial Efficacy of First-in-Class Small Molecule Imipridone Onc201 in Hematological Malignancies. Cell Cycle. 2018:1-11.

69. Randhawa S, Moore RF, DiSesa V, et al. Role of Thoracic Surgeons in Lung Cancer Screening: Opportune Time for Involvement. J Thorac Oncol. 2018;13(3):298-300. PMID: 29472053.

70. Riddle DL, Ghomrawi H, Jiranek WA, Dumenci L, Perera RA, Escobar A. Appropriateness Criteria for Total Knee Arthroplasty: Additional Comments and Considerations. J Bone Joint Surg Am. 2018;100(4):e22. PMID: 29462044.

71. Ristau BT, Kutikov A. Natural History of Complex Renal Cysts: Clinical Evidence Supporting Active Surveillance Editorial Comments. Journal of Urology. 2018;199(3):639-640.

72. Sartor O, Vogelzang NJ, Sweeney C, et al. Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First US Experience from an Expanded Access Program. Oncologist. 2018;23(2):193-202.

73. Schmier J, Ogden K, Nickman N, et al. Costs of Providing Infusion Therapy for Rheumatoid Arthritis in a Hospital-Based Infusion Center Setting. Clin Ther. 2017;39(8):1600-1617. PMID: 28716293.

74. Schootman M, Gomez SL, Henry KA, et al. Geospatial Approaches to Cancer Control and Population Sciences. Cancer Epidemiol Biomarkers Prev. 2017;26(4):472-475. PMID: 28325736. PMC5380532. NIHMS853745.

75. Seeger C. Control of Viral Transcripts as a Concept for Future Hbv Therapies. Curr Opin Virol. 2018;30:18-23. PMID: 29453098.

76. Seliga A, Lee MH, Fernandes NC, et al. Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation. Front Immunol. 2018;9:156. PMID: 29456540. PMC5801412.

77. Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch Repair Deficiency Testing in Patients with Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncology. 2018;4(2).

78. Soboloff J, Gligorijevic B, Zaidi MR. Stim1 (C)Amps up Melanogenesis. Embo j. 2018. PMID: 29449324.

79. Toland AE, Forman A, Couch FJ, et al. Clinical Testing of Brca1 and Brca2: A Worldwide Snapshot of Technological Practices. npj Genomic Medicine. 2018;3(1).

80. Toma M, Skorski T, Sliwinski T. DNA Double Strand Break Repair – Related Synthetic Lethality. Curr Med Chem. 2018. PMID: 29421999.

81. Westerberg BD, Lango MN. Otolaryngology-Related Disorders in Underserved Populations, Otolaryngology Training and Workforce Considerations in North America. Otolaryngol Clin North Am. 2018. PMID: 29482920.

82. Winer A, Nicholas Bodor J, Borghaei H. Identifying and Managing the Adverse Effects of Immune Checkpoint Blockade. Journal of Thoracic Disease. 2018;10:S480-S489.

83. Wu HC, Do C, Andrulis IL, et al. Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study. Epigenetics. 2018:1-23. PMID: 29436922.

84. Xiao X, Putatunda R, Zhang Y, et al. Lymphotoxin Beta Receptor-Mediated Nfkappab Signaling Promotes Glial Lineage Differentiation and Inhibits Neuronal Lineage Differentiation in Mouse Brain Neural Stem/Progenitor Cells. J Neuroinflammation. 2018;15(1):49. PMID: 29463313. PMC5819232.

85. Xu K, Yang WY, Nanayakkara GK, et al. Gata3, Hdac6, and Bcl6 Regulate Foxp3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg. Front Immunol. 2018;9:45. PMID: 29434588. PMC5790774.

86. Yamazaki J, Jelinek J, Hisamoto S, Tsukamoto A, Inaba M. Dynamic Changes in DNA Methylation Patterns in Canine Lymphoma Cell Lines Demonstrated by Genome-Wide Quantitative DNA Methylation Analysis. Vet J. 2018;231:48-54. PMID: 29429487.

87. Yu JQ, Doss M, Alpaugh RK. Normal Variants and Pitfalls Encountered in Pet Assessment of Gynecologic Malignancies. PET Clin. 2018;13(2):249-268. PMID: 29482753.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s